Acute haemothorax secondary to ibrutinib: A case report
- PMID: 36467786
- PMCID: PMC9713043
- DOI: 10.1002/jha2.367
Acute haemothorax secondary to ibrutinib: A case report
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- NHS England . Interim treatment change options during the Covid‐19 pandemic endorsed by NHS England. [Accessed 2021 Sep 1]. Available from: https://www.nice.org.uk/guidance/ng161/resources/interim-treatment-chang...
-
- McMullen JR, Boey EJ, Ooi JY, Seymour JF, Keating MJ, Tam CS. Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K‐Akt signalling. Blood 2014;124(25):3829–30. - PubMed
-
- Levade M, David E, Garcia C, Laurent P‐A, Cadot S, Michallet A‐S, et al. Ibrutinib treatment affects collagen and von Willebrand factor‐dependent platelet functions. Blood 2014;124(26):3991–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources